Return to content in this issue


Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy

Faihs V, Bent R, Darsow U, Biedermann T, Brockow K

Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany

J Investig Allergol Clin Immunol 2023; Vol 33(2) : 149-150
doi: 10.18176/jiaci.0829

Key words: SARS-CoV-2. COVID-19, Polyethylene glycol, mRNA vaccine, Anaphylaxis